glp-1 for autoimmune disease Health Feed Exploring glucagon-like peptide-1 receptor agonists
Description
GLP-1 reduces input
So when Stephen Bloom's paper came out in January of 1996, and he was the first one to call GLP-1 a neurotransmitter, I think, but I was already way into actually screening these kind of molecules that later then became liraglutide
Nonetheless, some commercial mimics of GLP-1, such as Liraglutide, even when administered peripherally, appear to cross the BBB and activate neurons within the ARC resulting in GABA dependent inhibition of neuropeptide Y (NPY) and agouti-related peptide (AgRP) secretion
Its proven ability to aid weight loss has lately been popular among people to help fight obesity
